Related Experiment Video

Updated: Sep 29, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.2K

Ferroptosis in Cardiovascular Diseases: Current Status, Challenges, and Future Perspectives

Yi Guo1,2, Chanjun Lu2, Ke Hu2

  • 1Clinic Center of Human Gene Research, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Biomolecules
|March 25, 2022
PubMed

Insights

Ferroptosis, a novel cell death, is crucial in cardiovascular diseases (CVDs). Targeting ferroptosis offers a promising therapeutic strategy for treating conditions like heart failure and atherosclerosis.

Area of Science:

  • Biomedical research
  • Cellular biology
  • Cardiovascular medicine

Background:

  • Cardiovascular diseases (CVDs) remain a leading cause of mortality and disability worldwide.
  • Understanding novel regulatory mechanisms is critical for effective CVD treatment.
  • Ferroptosis, a regulated form of cell death, is increasingly implicated in CVD pathogenesis.

Purpose of the Study:

  • To review the latest regulatory mechanisms of ferroptosis.
  • To summarize current research on ferroptosis in various CVDs.
  • To provide perspectives on ferroptosis-targeted therapies for CVDs.

Main Methods:

  • Literature review of ferroptosis and cardiovascular disease research.
  • Analysis of studies investigating ferroptosis in ischemia/reperfusion injury, heart failure, cardiomyopathy, and atherosclerosis.
  • Synthesis of findings to identify therapeutic potential.

Main Results:

  • Ferroptosis is involved in the pathophysiology of major cardiovascular diseases.
  • Specific molecular pathways regulating ferroptosis in CVDs have been identified.
  • Targeting ferroptosis demonstrates potential for mitigating CVD progression.

Conclusions:

  • Ferroptosis plays a significant role in cardiovascular diseases.
  • Targeting ferroptosis presents a promising therapeutic avenue for CVDs.
  • Further research is warranted to translate ferroptosis-targeting strategies into clinical practice.

Keywords:
atherosclerosiscardiomyopathycardiovascular diseasesferroptosisheart failureischemia/reperfusion injury

More Related Videos

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

4.1K
A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft08:30

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

Published on: February 14, 2022

2.8K

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.5K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
833
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
67
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
64
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
82